EAM
HAE icon

Eagle Asset Management’s Haemonetics HAE Stock Holding History

Eagle Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.79M Sell
100,565
-118,636
-54% -$9.58M 0.04% 320
2024
Q2 		$18.1M Sell
219,201
-42,472
-16% -$3.74M 0.1% 198
2024
Q1 		$22.2M Sell
261,673
-10,853
-4% -$852K 0.11% 178
2023
Q4 		$23.3M Buy
272,526
+3,883
+1% +$336K 0.13% 169
2023
Q3 		$24.1M Buy
268,643
+6,828
+3% +$610K 0.14% 160
2023
Q2 		$22.3M Buy
261,815
+43,270
+20% +$3.66M 0.12% 169
2023
Q1 		$18.1M Buy
+218,545
New +$17.7M 0.11% 173
2021
Q2 		– Sell
-57,172
Closed -$6.41M – 609
2021
Q1 		$6.41M Sell
57,172
-4,231
-7% -$524K 0.03% 387
2020
Q4 		$7.29M Sell
61,403
-7,061
-10% -$760K 0.04% 336
2020
Q3 		$5.95M Sell
68,464
-476
-0.7% -$41.6K 0.03% 343
2020
Q2 		$6.07M Sell
68,940
-452,922
-87% -$45.7M 0.03% 349
2020
Q1 		$52M Buy
521,862
+8,481
+2% +$920K 0.32% 116
2019
Q4 		$59M Sell
513,381
-82,551
-14% -$9.99M 0.28% 137
2019
Q3 		$75.2M Buy
595,932
+16,962
+3% +$2.15M 0.39% 92
2019
Q2 		$69.7M Buy
578,970
+16,803
+3% +$1.65M 0.36% 109
2019
Q1 		$49.2M Sell
562,167
-58
-0% -$5.28K 0.26% 155
2018
Q4 		$56.3M Buy
562,225
+102,649
+22% +$10.8M 0.35% 108
2018
Q3 		$52.7M Buy
+459,576
New +$47.6M 0.25% 165
2014
Q1 		– Sell
-107,462
Closed -$4.53M – 664
2013
Q4 		$4.53M Buy
107,462
+1,220
+1% +$50.2K 0.03% 454
2013
Q3 		$4.24M Buy
106,242
+19,408
+22% +$814K 0.02% 517
2013
Q2 		$3.59M Buy
+86,834
New +$3.52M 0.02% 516

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Eagle Asset Management's HAE Position: Q3 2024 in Review

Eagle Asset Management reduced its Haemonetics (HAE) stake by 54% in Q3 2024, selling an estimated $9.58M and leaving 100,565 shares worth $8.79M. The position accounts for 0.04% of the portfolio, ranked #320.

Eagle Asset Management first reported a position in HAE in Q2 2013 and has held it in 21 quarters since. The position peaked at $75.2M in Q3 2019. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Eagle Asset Management held 100,565 shares of Haemonetics worth $8.79M as of Q3 2024.
  • Eagle Asset Management sold 118,636 Haemonetics shares in Q3 2024, an estimated $9.58M.
  • Haemonetics made up 0.04% of Eagle Asset Management's portfolio in Q3 2024, its #320 holding.
  • Eagle Asset Management first reported a position in Haemonetics in Q2 2013 and has held it in 21 quarters since.
  • Eagle Asset Management's Haemonetics position peaked at $75.2M in Q3 2019.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.